NASDAQ: ACIUAc Immune Sa Stock Ownership - Who owns Ac Immune Sa?
Insider buying vs selling
Have Ac Immune Sa insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrea Pfeifer | Chief Executive Officer | 2026-05-15 | 10,000 | $2.79 | $27.93kSell |
| Andrea Pfeifer | Chief Executive Officer | 2026-04-15 | 10,000 | $3.14 | $31.43kBuy |
| Andrea Pfeifer | Chief Executive Officer | 2026-04-15 | 10,000 | $3.14 | $31.43kSell |
ACIU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACIU insiders and whales buy or sell their stock.
ACIU Shareholders
What type of owners hold Ac Immune Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Inc | 19.48% | 19,822,436 | $49.75M | Institution |
| Andrea Pfeifer | 3.77% | 3,834,288 | $9.62M | Insider |
| Wells Fargo Company | 0.99% | 1,004,284 | $2.52M | Institution |
| Millennium Management LLC | 0.78% | 792,657 | $1.99M | Institution |
| Renaissance Technologies LLC | 0.61% | 624,367 | $1.57M | Institution |
| Blackrock Inc | 0.52% | 524,278 | $1.32M | Institution |
| Arrowstreet Capital Limited Partnership | 0.40% | 405,658 | $1.02M | Institution |
| Dimensional Fund Advisors LP | 0.38% | 390,165 | $979.31k | Institution |
| Northern Trust Corp | 0.27% | 278,513 | $699.07k | Institution |
| Citadel Advisors LLC | 0.26% | 267,233 | $670.75k | Institution |
ACIU vs Biotech Stocks
Ac Immune Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.